The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has launched Global Health Progress, a new knowledge hub, to foster collaborations between the pharmaceutical companies in support of the sustainable development goals (SDG).
The platform lists over 200 collaborations between the innovative biopharmaceutical industry and more than 850 partners to support the SDGs. Users can explore collaborations by SDG target, disease area, program strategy, and more, a release said.
Many countries are facing challenge to tackle infectious disease challenges even as they also battle with an increasing prevalence of non-communicable diseases (NCDs), the release said.
Global Health Progress highlights over 200 collaborations which use innovative approaches to tackle global health challenges. The collaborations are helping to bring different actors together – governments, academia, multilateral organizations, other private sector companies, local NGOs and more – to catalyze cross-sector initiatives to tackle health related challenges, as well as address gender equality and education issues.
A range of program strategies are being used to address systemic health issues and lay foundations to sustain program gains. In consultation with local actors, IFPMA member companies are fostering local ownership of programs and designing programs according to country’s specific health needs and existing health system infrastructure.